Subscribe

Alcidion Group Limited (ALC.AX)

AUD0.10 +0.00 (+0.00%)
AU ASX Healthcare Medical - Healthcare Information Services
Address 9 Yarra Street 3141
South Yarra, VIC, AU
CEO Kate Quirke
Website alcidion.com
IPO 2011-06-24
ISIN AU000000ALC6

Explore sections of this company profile

Description

Alcidion Group Limited operates as a healthcare technology firm, specializing in the creation and licensing of software products across Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a consolidated platform built on the Fast Healthcare Interoperability Resources (FHIR) standard, aimed at enabling intelligent healthcare delivery. The company also supplies Smartpage, a mobile and web-based system designed to streamline hospital communications and task management for clinical and administrative personnel. Additional solutions include Patientrack, a tool for real-time patient monitoring and risk screening; Silverlink, which handles patient administration; and ExtraMed, software dedicated to optimizing clinical and patient flow. Furthermore, Alcidion provides a range of services encompassing product deployment, support and maintenance, systems integration, and data analysis. Founded in 2000 and headquartered in South Yarra, Australia, the company was formerly known as Alcidion Corporation Pty Ltd until its rebranding as Alcidion Group Limited in December 2015.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
AUD0.10 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
880.6K
Beta
1.10
Float Shares
993.21M
Free Float %
74.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.27% -6.52% +5.39% +2.38% +2.38% +2.38% +25.00% +8.59% -76.18% +128.30% -36.63%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.10
DCF (Unlevered) 0.02 -83.0%
DCF (Levered) 0.01 -86.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 75% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 3 0
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.50
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +10.1% Q4'25: +33.6% (vs Q4'23)
  • ✓
    EPS growth Medical - Healthcare Information Services: +43.1%
    +118.8% ★ Q4'25: +129.4% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +2.7% Q4'25: -10.2% (vs Q4'23)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    -1.4% Q4'25: +8.6% (vs Q4'23)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    -0.5% Q4'25: +9.8% (vs Q4'23)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +2.0% Q4'25: +4.1% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.73× ★ Q4'25: 0.07× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.12) × ERP
WACC = 99% × Ke + 1% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 0.02 Current price: 0.10
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Jun 2019
actual 		Jun 2020
actual 		Jun 2021
actual 		Jun 2022
actual 		Jun 2023
actual 		Jun 2024
actual 		Jun 2025
actual 		Jun 2026
4 Rev. Ana.
3 EPS Ana. 		Jun 2027
4 Rev. Ana.
3 EPS Ana. 		Jun 2028
4 Rev. Ana.
3 EPS Ana.
Revenue
16.86M
est: 16.60M (+1.6%)
18.55M
est: 21.00M (-11.7%)
25.88M
est: 25.70M (+0.7%)
34.36M
est: 33.60M (+2.2%)
40.40M
est: 39.85M (+1.4%)
37.06M
est: 38.85M (-4.6%)
40.79M
est: 40.97M (-0.4%)
47.55M
46.47M – 48.31M
+16.1% YoY
50.15M
47.51M – 54.18M
+5.5% YoY
54.08M
52.01M – 56.14M
+7.8% YoY
EBITDA
-91.8K
est: -576.3K (+84.1%)
-3.85M
est: -729.0K (-427.4%)
-474.0K
est: -892.2K (+46.9%)
-1.58M
est: -1.17M (-35.8%)
-1.43M
est: -1.38M (-3.2%)
-4.50M
est: 3.02M (-249.1%)
1.94M
est: 3.18M (-39.1%)
3.69M
3.61M – 3.75M
+16.1% YoY
3.89M
3.69M – 4.21M
+5.5% YoY
4.20M
4.04M – 4.36M
+7.8% YoY
EBIT
-157.7K
est: -1.69M (+90.6%)
-4.09M
est: -2.13M (-91.9%)
-931.0K
est: -2.61M (+64.3%)
-3.84M
est: -3.41M (-12.5%)
-4.62M
est: -4.05M (-14.0%)
-8.60M
est: -3.95M (-117.9%)
-564.0K
est: -4.16M (+86.4%)
-4.83M
-4.91M – -4.72M
-16.1% YoY
-5.09M
-5.50M – -4.82M
-5.5% YoY
-5.49M
-5.70M – -5.28M
-7.8% YoY
Net Income
-84.2K
-3.08M
-2.24M
est: -2.63M (+14.8%)
-4.41M
est: -6.71M (+34.3%)
-3.62M
est: -4.19M (+13.7%)
-8.42M
est: -7.37M (-14.2%)
1.65M
est: 811.4K (+103.8%)
1.13M
-155.3K – 2.33M
+38.6% YoY
2.58M
2.43M – 2.71M
+128.9% YoY
4.50M
1.13M – 8.86M
+74.8% YoY
SGA
14.47M
est: 11.82M (+22.4%)
6.83M
est: 14.96M (-54.3%)
17.93M
est: 18.31M (-2.0%)
22.96M
est: 23.93M (-4.1%)
29.14M
est: 28.38M (+2.7%)
29.20M
est: 27.67M (+5.5%)
28.18M
est: 29.18M (-3.4%)
33.87M
33.10M – 34.41M
+16.1% YoY
35.72M
33.84M – 38.59M
+5.5% YoY
38.52M
37.05M – 39.99M
+7.8% YoY
EPS
0.00
0.00
0.00
est: 0.00 (-12.1%)
0.00
est: -0.01 (+24.0%)
0.00
est: 0.00 (+6.5%)
-0.01
est: -0.01 (-17.4%)
0.00
est: 0.00 (+100.0%)
0.00
0.00 – 0.00
+54.2% YoY
0.00
0.00 – 0.00
+105.4% YoY
0.00
0.00 – 0.01
+72.4% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-28 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-27 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-26 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-25 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-22 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-21 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-20 B+ 3/5 3/5 3/5 4/5 4/5 1/5 3/5
2026-05-19 B 3/5 3/5 3/5 4/5 3/5 1/5 3/5
2026-05-18 B 3/5 3/5 3/5 4/5 3/5 1/5 3/5
2026-05-15 B+ 3/5 3/5 3/5 4/5 3/5 1/5 4/5
2026-05-14 B+ 3/5 3/5 3/5 4/5 3/5 1/5 4/5
2026-05-13 B+ 3/5 3/5 3/5 4/5 3/5 1/5 4/5
2026-05-12 B+ 3/5 3/5 3/5 4/5 3/5 1/5 4/5
2026-05-11 B+ 3/5 3/5 3/5 4/5 3/5 2/5 4/5
2026-05-08 B+ 3/5 3/5 3/5 4/5 3/5 2/5 4/5
2026-05-07 B+ 3/5 3/5 3/5 4/5 3/5 2/5 4/5
2026-05-06 B+ 3/5 3/5 3/5 4/5 3/5 2/5 4/5
2026-05-05 B+ 3/5 3/5 3/5 4/5 3/5 2/5 4/5
2026-05-04 B+ 3/5 3/5 3/5 4/5 3/5 2/5 4/5
2026-05-01 B+ 3/5 3/5 2/5 4/5 3/5 2/5 4/5
2026-04-30 B+ 3/5 3/5 2/5 4/5 3/5 2/5 4/5
2026-04-29 B+ 3/5 3/5 2/5 4/5 3/5 2/5 4/5
2026-04-28 B+ 3/5 3/5 2/5 4/5 3/5 2/5 4/5
2026-04-27 B+ 3/5 3/5 2/5 4/5 3/5 2/5 4/5
2026-04-24 B 3/5 3/5 2/5 4/5 2/5 2/5 4/5
2026-04-23 B+ 3/5 3/5 2/5 5/5 2/5 2/5 4/5
2026-04-22 B+ 3/5 3/5 2/5 5/5 2/5 2/5 4/5
2026-04-21 B+ 3/5 3/5 2/5 5/5 2/5 2/5 4/5
2026-04-20 B+ 3/5 3/5 2/5 5/5 2/5 2/5 4/5
2026-04-17 B+ 3/5 3/5 2/5 5/5 2/5 2/5 4/5
2026-04-16 B+ 3/5 3/5 2/5 5/5 2/5 2/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
7.49M
OE per share TTM
0.01
Owner's Yield
5.19%
Maintenance CapEx ratio
22.28%
Maint CapEx / Avg PPE
5.1%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-3.9K
Shares Outstanding
1.34B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Kate Quirke Group MD, Chief Executive Officer & Executive Director 747.1K female
Matthew Gepp Chief Financial Officer 434.1K male
Julia Stevens Chief Operating Officer 369.6K female
Nick White Chief Marketing Officer — male
Paul Deffley Chief Medical Officer and Managing Director of UK — male
Amanda James Chief People Officer — female
Sean Walker Chief Technology Officer — male
Kaye Hocking Chief Product Officer — female
Michael Sapountzis Company Secretary — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services